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Haemosiderotic synovitis is a rare condition caused by recurrent or chronic haemarthroses. This may lead to intra-articular
destruction, a painful joint, and, if untreated, ankylosis of the joint. We highlight a case of an elderly lady who presented to an
orthopaedic clinic with left knee pain, following recurrent left knee atraumatic haemarthroses secondary to oral anticoagulant
use. At her presentation, she had a left medial unicompartmental knee prosthesis in situ. Weight bearing radiographs of the left
knee showed marked loss of lateral joint space with valgus alignment. These radiographic ﬁndings were not present on the
radiographs taken at her ﬁrst presentation with haemarthrosis nine months previously. A left revision total knee arthroplasty
was performed, and a diagnosis of haemosiderotic synovitis was made following histological analysis of intraoperative tissue
samples. This case highlights an unusual mechanism of failure of a unicompartmental knee replacement. Though
haemosiderotic synovitis is an exceedingly rare condition, it must be considered following recurrent haemarthrosis as, due to its
destructive nature, prompt recognition and treatment is paramount.
1. Introduction
Haemosiderotic synovitis is a proliferative synovial disorder
that develops as the result of recurrent or chronic haemar-
throses [1–4]. Although exceedingly rare in nonhaemophi-
liac populations, oral anticoagulant use amongst other
causes has been documented in the literature [3]. Haemosi-
derotic synovitis most commonly aﬀects the knee joint,
owing to this joint’s propensity to articular haemorrhage
[1]. The synovial proliferation induced through haemarthro-
sis, theorised to be the results of the iron-induced mdm2 and
c-myc oncogene expression and increases in VEGF levels,
leads to a hypertrophic and hyperaemic synovium more
susceptible to haemorrhage, thus establishing a cycle of
recurrent inﬂammation and haemarthroses [5–7]. Chronic
haemosiderotic synovitis can result in intra-articular synovial
ﬁbrosis, capsular ﬁbrosis, and cartilage destruction, ulti-
mately leading to an ankylosed, dysfunctional joint [4, 8].
We describe a case of nonhaemophiliac haemosiderotic
synovitis following recurrent warfarin-related atraumatic
haemarthrosis in a woman presenting with worsening left
knee pain and a previous unicompartmental left knee
prosthesis.
2. Case Presentation
A 77-year-old woman presented to an orthopaedic clinic
with an eight-month history of pain in her left knee and
recurrent haemarthroses within this joint whilst taking war-
farin. She had uncomplicated bilateral unicompartmental
knee replacements with the left in 2010 and the right in
2008. Over the previous nine months, she was admitted to
the Emergency Department four times with haemarthrosis
of the left knee joint and supratherapeutic International
Normalised Ratios (INR), each time improving with con-
servative management. The most recent haemarthrosis,
one month previously, was subsequently aspirated. No
bacterial cultures were grown from this sample, and a
Synovasure Alpha Defensin Test was negative. At the time
of her presentation to clinic, she had been on warfarin for
ﬁve years following recurrent deep vein thromboses and a
pulmonary embolus. Her past medical history was notable
for insulin managed type 2 diabetes mellitus, hypertension,
hyperlipidaemia, and chronic renal impairment. Although
initially able to mobilise with a four-wheeled frame, when
she presented to the clinic, her mobility had deteriorated
and was unable to weight bear, using a wheelchair to
mobilise. Examination showed a well-healed surgical scar,
an antalgic gait, mild knee swelling, and a partially cor-
rectable 20° valgus deformity of the left knee. Her range
of movement was 0-90°.
Her INR was 1.9 (therapeutic range 2.0–3.0). Haemoglo-
bin was 13.6 (normal range: 11.7–15.5 g/dL). White Cell
Count was 7.4 (normal range: 4:1 – 11:2 × 103/μL), and
CRP was 3.5 (normal range: 1–5mg/L). Urea and electrolytes
were within normal range.
Weight-bearing long-leg radiographs demonstrated
bilateral unicompartmental knee replacements. There was a
prominent valgus (20°) deformity of the left knee with loss
of lateral compartment joint space with associated subchon-
dral sclerosis and infarction of the lateral femoral condyle
(Figures 1 and 2). These radiographic ﬁndings were not
present on a radiograph taken at her ﬁrst presentation with
haemarthrosis nine months previously (Figure 3).
Following discussion with the haematologist, warfarin was
stopped and bridging Clexane used. The patient underwent
revision of the left unicompartmental knee to a total knee
replacement through a lateral parapatella approach. Intraop-
eratively, computer navigation was utilised (Brainlab, Munich,
Germany) to aid alignment and ligament balancing. A short-
stemmed tibial component was used and a posterior stabilised
Figure 1: Long-leg radiographs demonstrating bilateral medial
unicompartmental knee replacements. Valgus deformity of the left
knee with loss of lateral joint space.
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Figure 2: Weight-bearing AP radiograph of the left knee. Medial
unicompartmental knee replacement in situ. Loss of lateral joint
space, subchondral sclerosis, and infarction of the lateral femoral
condyle.
Figure 3: Weight-bearing AP radiograph of the left knee from nine
months prior to presentation. Medial unicompartmental knee
replacement in situ.
2 Case Reports in Orthopedics
knee component. The lateral femoral condyle was delami-
nated, and the cartilage was haemosiderin stained (Figure 4).
Intraoperative samples conﬁrmed no infection, and histology
conﬁrmed the diagnosis of haemosiderotic synovitis.
Postoperatively, the patient had made good progress at
six weeks. She had no pain and a stable knee through a ﬂex-
ion of 0-100°. At six months of follow-up, she was walking
with a single point stick at home and managed to go shop-
ping with her husband. Her knee was stable with ﬂexion
maintained at 0-100°. Oxford knee scores had improved from
17 preoperatively to 38 at six months. Radiographs showed
good alignment of the revision left total knee replacement
(Figures 5–7). Informed written consent was obtained from
the patient for production of this case report.
3. Discussion
In this case, we highlight an unusual mechanism of failure of
a unicompartmental knee replacement. Here, recurrent
haemarthroses in a patient on oral anticoagulant were
complicated by haemosiderotic synovitis. The most common
causes of failure of unicompartmental failure knee replace-
ments vary depending on the bearing design. With ﬁxed
bearings, polyethylene wear and aseptic loosening constitute
the majority of cases necessitating conversion to total knee
arthroplasty, whereas with mobile bearings, bearing disloca-
tion is the most common indication for revision [9]. Another
common mode of failure of a unicompartmental knee
replacement—progression of osteoarthritis—is excluded by
the radiographs taken at her ﬁrst presentation with haemar-
throses nine months previously (Figure 3).
Patients with haemosiderotic synovitis commonly pres-
ent with pain and stiﬀness of the involved joint, often due
to secondary osteoarthritis development [1, 10]. However,
Figure 4: Clinical photo of the left knee with a lateral parapatellar
exposure. Medial unicompartmental knee replacement in situ.
Haemosiderin staining of the lateral femoral condyle.
Figure 5: Postoperative AP radiograph of the left knee. Revision left
total knee in situ. Pin holes used for navigation are present distal to
the stemmed tibial component.
Figure 6: Postoperative lateral radiograph of the left knee. Revision
left total knee in situ. Pin holes used for navigation are present distal
to the stemmed tibial component.
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these symptoms may also represent severe osteoarthritis,
rheumatoid arthritis, or pigmented villonodular synovitis,
thus making a clinical diagnosis of haemosiderotic synovitis
extremely diﬃcult [3, 10]. As found with this patient, a
history of recurrent haemarthrosis is a key component of
the disease pathology and is most commonly the result of
inherited clotting factor deﬁciencies [1, 10].
In haemosiderotic synovitis, recurrent, or chronic, hae-
marthroses induce synovial proliferation and establish a
vicious cycle of recurrent inﬂammation and haemarthrosis
[5–7]. Though the pathology of haemosiderotic synovitis
has not been fully characterised, it is theorised that iron-
induced angiogenesis through VEGF signalling and
mdm2 and c-myc oncogene upregulation results in the
development of a hyperaemic and hypertrophic synovium
more susceptible to haemorrhage. Although this disease
entity is exceedingly rare in nonhaemophiliac populations,
other documented causes include oral anticoagulant use,
trauma, rheumatoid or psoriatic arthritis, collagen vascular
disease, and myeloproliferative disorders [1]. Chronic hae-
mosiderotic synovitis ultimately results in intra-articular
synovial ﬁbrosis, capsular ﬁbrosis, and cartilage destruction
leading to an ankylosed, dysfunctional joint [4, 8, 11].
The diagnosis of haemosiderotic synovitis can only be
made histologically following sampling of the synovium
[10]. Accumulation of haemosiderin leads to rusty brown
discolouration of the tissue and loss of the normal glisten-
ing translucent appearance of the synovial membrane [12].
Though this gross macroscopic appearance is often indis-
tinguishable from pigmented villonodular synovitis, in
haemosiderotic synovitis, there is no proliferation of mono-
nuclear synovial cells, lipid-laden cells, or multinucleated
osteoclast-like giant cells [1, 10, 12]. As such, microscopic
examination is essential to conﬁrm the diagnosis.
Though rare, cases of nonhaemophiliac haemosiderotic
synovitis have been noted in the literature involving several
joints [1, 3, 10]. Yalçin et al. described a case of a 20-year-
old female presenting with recurrent atraumatic joint eﬀu-
sions which, following histological analysis, was found to be
the result of haemosiderotic synovitis and was successfully
treated arthroscopically [10]. Furthermore, a previous case
report described a case of haemosiderotic synovitis present-
ing as pain and swelling of the left knee [1]. Interestingly,
in this case, there was no history of bleeding diatheses or anti-
coagulant use and the cause of this patient’s haemosiderotic
synovitis was unclear. Though the knee is the most common
site of haemosiderotic synovitis, due to its susceptibility to
haemarthroses, this condition has been documented to aﬀect
other joints, including the shoulder [3].
Once a diagnosis of haemosiderotic synovitis is sus-
pected, prompt treatment is paramount. Due to paucity of
documented cases of haemosiderotic synovitis, the most
eﬀective treatment option remains unclear, and no studies
have assessed the eﬀectiveness of therapies in nonhaemophi-
liac populations. Radiosynovectomy, arthroscopic synovect-
omy, and radio-isotopic joint injection, aimed at reducing
the frequency and intensity of haemarthroses, have been sug-
gested to be eﬀective in the initial management of haemosi-
derotic synovitis in patients with haemophilia [11, 13–15].
Total knee arthroplasty is indicated if there is loss of joint
space, severe pain, or evidence of deformity.
Importantly, as many of these patients have complex
haematological needs, a multidisciplinary approach is par-
amount. Management of coagulation deﬁcits or anticoagu-
lation is essential to prevent further haemarthrosis or the
development of chronic haemarthrosis. Additionally, it is
important to consider the preoperative and postoperative
haematological needs of these patients and monitor their
clotting proﬁles closely to prevent complications such as
bleeding or thromboembolic events.
Although rare, haemosiderotic synovitis is an impor-
tant consideration in patients presenting with knee pain
following haemarthroses. Suspicion should further be
raised if there is a history of haemophilia or suprathera-
peutic oral anticoagulant use. Given the destructive nature
of this condition and the risk of ankylosing deformity,
prompt recognition and treatment with a multidisciplinary
approach is paramount.
Figure 7: Long-leg radiographs demonstrating a medial
unicompartmental knee replacement and revision left total knee
replacement at six months.
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